Akso Health Group current report, Q4 FY2019

SEC Filing Summary: Hexindai Inc. (Form 6-K)

Business Context and Reporting Period

This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of December 2019. The filing was signed on December 19, 2019, by Zhang Rui (Kerrie), Chief Financial Officer. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing indicates the company files annual reports under Form 20-F.

Financial Metrics

The provided filing text contains only the cover page and exhibit index. It does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The filing references an attached press release (Exhibit 99.1) which is not included in the source text.

Material Changes

No material changes versus the prior comparable period are described in the provided text, as the document lacks financial data or operational updates.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are likely contained within the referenced press release (Exhibit 99.1), which is not present in the input.

Key Facts for Investor Verification

  • Verify the content of Exhibit 99.1 (Press Release) to obtain actual financial results or material announcements for December 2019.
  • Confirm the company name discrepancy: The filing is for Hexindai Inc., while the request metadata referenced "Akso Health Group."
  • Review the full Form 20-F for comprehensive annual financial data, as this 6-K is a limited report.